Source: Translational Research in Oncology From: finance.yahoo.com Translational Research in Oncology (TRIO), a global academic clinical research organization, announced today enrolment completion in coopERA Breast Cancer (WO42133/TRIO038), a Phase 2 randomized, multi-center, open-label clinical trial of giredestrant (GDC-9545) sponsored by F. Hoffmann-La Roche. This comes shortly after completion of the planned study interim analysis provided encouraging results and supported continuation …
-
-
Regrets After a Cancer Diagnosis
-
You Are Not Alone After a Breast Cancer Diagnosis
-
The Past and Future Collide After a Breast Cancer Diagnosis
-
Focusing on the Positive After a Breast Cancer Diagnosis
-
My Message of Easter for the Breast Cancer Community
